Welcome to LookChem.com Sign In|Join Free

CAS

  • or

176894-58-9

Post Buying Request

176894-58-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

176894-58-9 Usage

Description

(R)-Benzyl 1-cyanoethylcarbaMate, a carbamate derivative with the molecular formula C14H15NO2, features a benzyl group attached to the nitrogen atom. This chemical compound is recognized for its role as a chiral auxiliary in asymmetric synthesis, enabling the introduction of stereochemical control in various chemical reactions. It is also known for its stability under normal conditions and low toxicity, making it a versatile compound in the chemical and pharmaceutical industries.

Uses

Used in Organic Synthesis:
(R)-Benzyl 1-cyanoethylcarbaMate is used as a reagent in organic synthesis for its ability to introduce stereochemical control in chemical reactions. This property is crucial for the development of enantiomerically pure compounds, which are essential in various applications, including pharmaceuticals and agrochemicals.
Used in Pharmaceutical Research:
In the pharmaceutical industry, (R)-benzyl 1-cyanoethylcarbaMate serves as a valuable chiral auxiliary, aiding in the development of new drugs with improved efficacy and selectivity. Its role in asymmetric synthesis allows for the creation of chiral molecules with specific configurations, which can significantly impact the drug's activity and safety profile.
Used in Agricultural Products:
(R)-Benzyl 1-cyanoethylcarbaMate also has potential applications in the development of agricultural products, where stereochemistry plays a vital role in the effectiveness and selectivity of active ingredients. Its use in asymmetric synthesis can contribute to the creation of more targeted and environmentally friendly agrochemicals.
Overall, (R)-benzyl 1-cyanoethylcarbaMate's unique structural and chiral properties make it a valuable compound in both the chemical and pharmaceutical industries, with applications ranging from organic synthesis to the development of new drugs and agricultural products.

Check Digit Verification of cas no

The CAS Registry Mumber 176894-58-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,6,8,9 and 4 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 176894-58:
(8*1)+(7*7)+(6*6)+(5*8)+(4*9)+(3*4)+(2*5)+(1*8)=199
199 % 10 = 9
So 176894-58-9 is a valid CAS Registry Number.

176894-58-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name benzyl N-[(1R)-1-cyanoethyl]carbamate

1.2 Other means of identification

Product number -
Other names B-1729

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:176894-58-9 SDS

176894-58-9Relevant articles and documents

C-terminal 1-aminoethyltetrazole-containing oligopeptides as novel alanine racemase inhibitors

Anderson, Rosaleen J.,Gray, Mark,Kondacs, Laszlo A.,Marrs, Emma C. L.,Orenga, Sylvain,Perry, John D.

, (2020/03/19)

In clinical culture media inoculated with patient samples, selective inhibition of commensal bacteria is essential for accurate diagnosis and effective treatment, as they can mask the presence of pathogenic bacteria. The alanine analogue, 1-aminoethyltetr

P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN

-

Page/Page column 67, (2010/11/18)

The subject invention relates to novel P2X3 receptor antagonists that play a critical role in treating disease states associated with pain, in particular peripheral pain, inflammatory pain, or tissue injury pain that can be treated using a P2X3 receptor subunit modulator.

Design and synthesis of cyclopenta[g]quinazoline-based antifolates as inhibitors of thymidylate synthase and potential antitumor agents

Bavetsias, Vassilios,Marriott, Jonathan H.,Melin, Camille,Kimbell, Rosemary,Matusiak, Zbigniew S.,Boyle, F. Thomas,Jackman, Ann L.

, p. 1910 - 1926 (2007/10/03)

Following the development of raltitrexed, the synthesis of nonpolyglutamatable inhibitors of TS that do not use the reduced folate carrier (RFC) for cellular entry should provide compounds which overcome mechanisms of resistance to folate-based inhibitors

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 176894-58-9